Woodline Partners’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $5.47M | Buy |
|
|||||
|
2025
Q1 | $6.01M | Buy |
|
|||||
|
2024
Q4 | $13.5M | Sell |
|
|||||
|
2024
Q3 | $35.1M | Sell |
|
|||||
|
2024
Q2 | $43.5M | Buy |
|
|||||
|
2024
Q1 | $19.8M | Buy |
|
|||||
|
2023
Q4 | $5.79M | Buy |
|
|||||
|
2023
Q3 | $3.01M | Sell |
|
|||||
|
2023
Q2 | $4.3M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $4.58M | Sell |
|
|||||
|
2022
Q1 | $7.84M | Buy |
|
|||||
|
2021
Q4 | $6.12M | Buy |
|
|||||
|
2021
Q3 | $3.51M | Sell |
|
|||||
|
2021
Q2 | $4.68M | Sell |
|
|||||
|
2021
Q1 | $5.94M | Sell |
|
|||||
|
2020
Q4 | $10.3M | Buy |
|
|||||
|
2020
Q3 | $5.39M | Buy |
|